期刊文献+

恶性肿瘤患者念珠菌感染的主要临床特征分析 被引量:6

Main Clinical Characteristics Analysis of Candida Species Infection in Patients with Malignant Tumors
下载PDF
导出
摘要 目的了解恶性肿瘤患者念珠菌感染临床的特点,分析念珠菌感染的危险因素,为念珠菌感染的预防和监控提供指导作用。方法采用查阅病历的方法,收集2004年1月~2005年12月在唐山市人民医院住院并发生念珠菌感染的恶性肿瘤患者的相关资料。结果785例恶性肿瘤患者念珠菌感染率为21.02%;念珠菌类型主要是白色念珠菌(77.78%),其次为光滑念珠菌(11.77%)。最易发生感染的部位是口腔及上呼吸道,占55.75%。性别对念珠菌感染没有影响,主要危险因素为年龄≥60岁、住院时间长、肿瘤分期晚、接受化疗及放疗、广谱抗生素和激素的大量使用、各种侵入性诊疗操作的应用等。结论念珠菌是临床重要的条件致病菌,免疫力低下是恶性肿瘤患者发生念珠菌感染的重要原因,必须重视念珠菌感染的预防和监控。 Objective To investigate clinical characteristics and risk factors of Candida species infection in patients with malignant tumors for the guidance of the prevention and surveillance of Candida infection. Methods A retrospective clinical study was performed in Tangshan people's hospital for 24 months (January 2004 to December 2005). In 785 patients with malignant tumor, clinical records of 153 patients with Candida infection were collected. Results Candida infection rate was 21. 1)2%. The major Candida species was Candida albicans(77. 78 %), the second was Candida glabrata (11.77%). The main locations of infection were mouth cavity and upper respiratory tract(55.75 %). Sex had no influence on Candida infection. The main risk factors were age ≥61) years, long-term hospitalzation, cancer stage, chemotherapy and radiotherapy, comprehensive application of antibiotics and hormones, diverse aggressive techniques of diagnosis and treatment. Conclusion Candida species is a major opportunistic pathogen. Candida infection was the result of advances in medical treatment and increasing numbers of immunocompromised patients with cancer. The prevention and surveillance of Candida infection must be emphasized.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2007年第6期454-456,共3页 Cancer Research on Prevention and Treatment
关键词 恶性肿瘤 念珠菌 危险因素 临床特征 Malignant tumors Candida species Risk factors
  • 相关文献

参考文献10

二级参考文献20

  • 1卢建平,张翊.医院内真菌感染临床分析[J].中华医院感染学杂志,2004,14(3):344-346. 被引量:95
  • 2乐晓峰,杨天楹.白血病和骨髓移植患者合并深部霉菌感染的防治进展[J].中华血液学杂志,1995,16(7):385-387. 被引量:14
  • 3刘利,刘思纯.白血病患者医院感染的临床分析[J].白血病,1996,5(3):164-165. 被引量:28
  • 4Bow EJ, Louie TJ.Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection[J].CMAJ, 1987, 137(5): 397.
  • 5Bow EJ. Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer [J]. Br J Haematol,1998,101(Suppl 1):1- 4.
  • 6Panagopoulou P,Filioti J,Petrikkos G,et al. Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece [J]. J Hosp Infect,2002,52(3):185- 191.
  • 7St-Germain G, Laverdiere M, Pelletier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada [J]. J Clin Microbiol,2001,39(3):949- 953.
  • 8Mullen CA,Abd El-Baki H,Samir H,et al. Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients [J]. Support Care Cancer, 2003,11(5):321- 325.
  • 9Nucci M, Silveira MI, Spector N, et al. Risk factors for death among cancer patients with fungemia [J]. Clinical Infectious Diseases, 1998,27(1):107- 111.
  • 10Bow EJ, Laverdiere M, Lussier N, et al. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials [J]. Cancer,2002,94(12):3230- 3246.

共引文献416

同被引文献37

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部